Research Programs

MUSC Hollings Cancer Center's mission to reduce the cancer burden in South Carolina begins with innovative and groundbreaking research. Through translational science centered around cancer biology, cancer control, cancer immunology, and developmental cancer therapeutics, our more than 120 scientists aim to find cures and improve the quality of life for those living with cancer.

Cancer Biology

cancer biology circus plot

By identifying and characterizing genetic and regulatory abnormalities that affect cancer and how they contribute to tumor growth and progression, researchers can develop potential targets for diagnosing, predicting, and treating cancer to help patients have better outcomes.

Cancer Control

map of south carolina

Hollings’ goal is to reduce cancer morbidity and mortality in South Carolina while providing scientific evidence and novel interventions that can be applied beyond the state’s borders. This program is focused on two main themes: cancer health disparities and tobacco control.

Cancer Immunology

immune cells

A patient’s own immune system can influence the growth and progression of their tumors. This program aims to develop innovative immunotherapeutic strategies to treat cancer and to understand the mechanisms of how a patient may tolerate these therapies.

Cancer Therapeutics

test tubes filled with blue liquid

The most important part of translational science is getting new treatments to the bedside of patients. This program focuses on discovering and characterizing important cancer-specific pathways, identifying new therapeutic agents, and translating these discoveries into effective cancer therapies.